KOO vs. INS, RENX, COG, INHC, IQAI, FDBK, DVRG, TRLS, SENS, and EMIS
Should you be buying Kooth stock or one of its competitors? The main competitors of Kooth include Instem (INS), Renalytix (RENX), Cambridge Cognition (COG), Induction Healthcare Group (INHC), IQ-AI (IQAI), Feedback (FDBK), DeepVerge (DVRG), Trellus Health (TRLS), Sensyne Health (SENS), and EMIS Group (EMIS). These companies are all part of the "health information services" industry.
Kooth vs.
Kooth (LON:KOO) and Instem (LON:INS) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership, community ranking and valuation.
Instem received 83 more outperform votes than Kooth when rated by MarketBeat users. However, 90.91% of users gave Kooth an outperform vote while only 52.25% of users gave Instem an outperform vote.
65.0% of Kooth shares are owned by institutional investors. Comparatively, 65.9% of Instem shares are owned by institutional investors. 17.3% of Kooth shares are owned by insiders. Comparatively, 30.0% of Instem shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Kooth has a net margin of 7.89% compared to Instem's net margin of 5.50%. Kooth's return on equity of 23.83% beat Instem's return on equity.
Kooth has higher earnings, but lower revenue than Instem. Instem is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.
Kooth currently has a consensus price target of GBX 585, indicating a potential upside of 232.39%. Given Kooth's stronger consensus rating and higher possible upside, research analysts plainly believe Kooth is more favorable than Instem.
Kooth has a beta of 0.71, suggesting that its stock price is 29% less volatile than the S&P 500. Comparatively, Instem has a beta of 0.42, suggesting that its stock price is 58% less volatile than the S&P 500.
In the previous week, Kooth had 2 more articles in the media than Instem. MarketBeat recorded 2 mentions for Kooth and 0 mentions for Instem. Kooth's average media sentiment score of 1.47 beat Instem's score of 0.00 indicating that Kooth is being referred to more favorably in the media.
Summary
Kooth beats Instem on 11 of the 17 factors compared between the two stocks.
Get Kooth News Delivered to You Automatically
Sign up to receive the latest news and ratings for KOO and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools
This page (LON:KOO) was last updated on 1/19/2025 by MarketBeat.com Staff